Iurii Titarenko - Revision history

Valentin: Add complete multilingual reference and language navigation

2026-11-12T00:52:25Z

Add complete multilingual reference and language navigation

← Older revision		Revision as of 00:52, 12 November 2026
Line 1:		Line 1:
			<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Iurii Titarenko\|English]] · [[Iurii Titarenko/uk\|Українська]] · [[Iurii Titarenko/es\|Español]] · [[Iurii Titarenko/fr\|Français]] · [[Iurii Titarenko/de\|Deutsch]] · [[Iurii Titarenko/pt\|Português]]</div>
	'''Iurii Titarenko''', also published as '''Yurii Titarenko''' (Ukrainian name in its original script: Тітаренко Юрій Анатолійович), is a contributor to publications on digital-health technologies, pharmaceutical research and medicines regulation. His identity anchor is [https://orcid.org/0009-0002-8664-9013 ORCID 0009-0002-8664-9013], linked in publisher author records.		'''Iurii Titarenko''', also published as '''Yurii Titarenko''' (Ukrainian name in its original script: Тітаренко Юрій Анатолійович), is a contributor to publications on digital-health technologies, pharmaceutical research and medicines regulation. His identity anchor is [https://orcid.org/0009-0002-8664-9013 ORCID 0009-0002-8664-9013], linked in publisher author records.

Valentin: Document public pre-2021 research with English descriptions and evidence levels

2026-11-12T00:13:18Z

Document public pre-2021 research with English descriptions and evidence levels

← Older revision		Revision as of 00:13, 12 November 2026
Line 21:		Line 21:

	[[Category:People]]		[[Category:People]]

			== Earlier bibliographic record ==
			A [https://umj.com.ua/en/publication-90400-psixosomaticheskie-rasstrojstva-v-obshhej-praktike 2015 Ukrainian Medical Journal review] cites Yu. A. Titarenko, E. G. Chuprikova and A. P. Chuprikov (2005), ''Psychological Stress and Stress-Analysis'' (editorial English translation; original: ''Психологический стресс и стресс-анализ''), Kyiv. This documents an earlier work through a later published reference; it does not mean the original book was examined here. No clinical-effectiveness or specific intellectual-genealogy claim is inferred. See [[Research before 2021]].

Valentin: Use English explanations and translated titles while preserving source identification

2026-11-12T00:10:15Z

Use English explanations and translated titles while preserving source identification

← Older revision		Revision as of 00:10, 12 November 2026
Line 1:		Line 1:
	'''Iurii Titarenko''', also published as '''Yurii Titarenko''' (Тітаренко Юрій Анатолійович), is a contributor to publications on digital-health technologies, pharmaceutical research and medicines regulation. His identity anchor is [https://orcid.org/0009-0002-8664-9013 ORCID 0009-0002-8664-9013], linked in publisher author records.		'''Iurii Titarenko''', also published as '''Yurii Titarenko''' (Ukrainian name in its original script: Тітаренко Юрій Анатолійович), is a contributor to publications on digital-health technologies, pharmaceutical research and medicines regulation. His identity anchor is [https://orcid.org/0009-0002-8664-9013 ORCID 0009-0002-8664-9013], linked in publisher author records.

	== Dated institutional context ==		== Dated institutional context ==

Valentin: Add publicly sourced Iurii Titarenko record and documented collaborations

2026-11-11T23:59:08Z

Add publicly sourced Iurii Titarenko record and documented collaborations

New page

'''Iurii Titarenko''', also published as '''Yurii Titarenko''' (Тітаренко Юрій Анатолійович), is a contributor to publications on digital-health technologies, pharmaceutical research and medicines regulation. His identity anchor is [https://orcid.org/0009-0002-8664-9013 ORCID 0009-0002-8664-9013], linked in publisher author records.

== Dated institutional context ==
The [https://srumpl.org/ena/Management.html SRUMPL management page], marked updated 16 May 2026, lists him as Head of Scientific Sector of Innovative Digital Medical Technologies, PhD in Psychology. This is the role stated by that institutional source; it does not establish medical licensure or a clinical specialty.

== Documented collaborative work ==
* '''2024, falsified-medicine risks:''' Yurii Titarenko and [[Valentyn Shapovalov]], ''The Latest Quantum and Medical, Quantum and Pharmaceutical Technologies in Countering the Criminal and Legal, Forensic and Pharmaceutical Risks of Circulation of Falsified Drugs''. [https://archive.sreif.us/index.php/mlp/article/view/149 Primary record], DOI 10.53933/sspmlp.v4i2.149. This documents the authors' proposed technology-related approach, not demonstrated effectiveness.
* '''2024, formulation and quality:''' Valentyn Shapovalov, [[Viktoriia Shapovalova]], [[Alina Osyntseva]], [[Valerii Shapovalov]], [[Oleksandr Veits]] and Yurii Titarenko, ''Multidisciplinary context of research of a new drug in infectious and inflammatory diseases''. [https://journals.uran.ua/ami/article/view/306931 Primary record], DOI 10.5281/zenodo.13820208. The work concerns paracetamol/ascorbic-acid tablets, standardization and quality control; it is not a clinical efficacy trial.
* '''2025, antituberculosis medicines:''' Oleksandr Nevzghoda, Alina Osyntseva, Valentyn Shapovalov, Iurii Titarenko, Viktoria Dovzhuk, Viktoriia Shapovalova and Valerii Shapovalov, ''Content analysis of combined anti-tuberculosis drugs''. [https://journals.uran.ua/ami/article/view/329329 Primary record], DOI 10.5281/zenodo.15662640. This is a medicines-market, registration and formulary analysis.

== Individually authored publications ==
* '''2026:''' ''The Role of Digital Health Technology in Personalized Allergy Therapy'', published 16 March 2026, 6(1):102–118. [https://ssp.sreif.us/index.php/mpm/article/view/32 Primary record], DOI 10.53933/wv26wm48. This narrative review uses content analysis, SWOT and PESTEL to discuss telemedicine, telepharmacy, AI, wearables, pharmacogenetics and personalized care. Its abstract calls for further clinical research and regulation.
* '''2025:''' ''Plasma Medicine: Innovative Methods of Diagnosis and Treatment of Chronic Wounds and Oncological Diseases''. [https://archive.sreif.us/index.php/mpm/article/view/174 Primary record], DOI 10.53933/sspmpm.v5i1.174.
* '''2024:''' ''Application of Innovative Digital Medical Technologies of Bioquantum Medicine and Therapy in Elimination of Allergy Symptoms''. [https://archive.sreif.us/index.php/mpm/article/view/156 Primary record], DOI 10.53933/sspmpm.v4i3.156.
* '''2024:''' ''Bioresonance Therapy as an Innovative Method of Bioquantum Medicine''. [https://archive.sreif.us/index.php/mpm/article/view/166 Primary record], DOI 10.53933/sspmpm.v4i4.166.

== Evidence and attribution ==
The bioresonance and “bioquantum medicine” titles are catalogued as the author's publications and claims, not as established clinical treatment effectiveness. Digital-health tools, plasma research and bioresonance are distinct topics; their inclusion in one author's bibliography does not give them the same evidence base. This entry is a publication guide, not treatment advice.

Coauthorship establishes a connection on the cited work, not supervision, equal contribution or endorsement of all later concepts. No personal ResearchGate or Google Scholar profile is linked without a secure identity match. See [[Research network]] and [[People and attribution]].

[[Category:People]]